Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The aim is to study the effect of a systematic approach to symptom identification and management with disease specific and clinically developed PRO (HM-PRO) with a 12 month follow up in outpatient care in patients with chronic hematological malignancy.
Epistemonikos ID: 862eb89f536ae8d02d1fe6bd67dee40f148101fd
First added on: Jan 21, 2022